Xiaolang Jiang, Shuai Ju, Bin Chen, Junhao Jiang, Yun Shi, Tao Ma, Changpo Lin, Xin Xu, Weiguo Fu, Zhihui Dong
PURPOSE: To evaluate the safety and effectiveness of excimer laser ablation (ELA) combined with drug-coated balloon (DCB) for atherosclerotic obliterans (ASO) of the lower extremities. MATERIALS AND METHODS: From June 2019 to December 2020, all eligible patients were enrolled. Demographics, characteristics of lesions, complications, and follow-up information were collected and analyzed. The primary endpoint was major amputation-free survival (MAFS). Secondary endpoints included technical success, primary patency, bailout stent, distal embolization, target lesion reintervention (TLR), and ulcer healing rate...
May 6, 2022: Journal of Endovascular Therapy